The management team of Frontage Laboratories, Inc. has the desire to ensure your success through every interaction with our company. Over the years of our operation, we have developed excellent relationships with some of the best pharmaceutical services companies in the business. The companies listed below can operate seamlessly with our development services to provide one-stop drug development and commercialization services for your projects. Please contact our sales team at 610-232-0100 to learn more about how we can help to accomplish your drug development goals!

Clinical Research Organizations (CRO's)

Phase I – IV NCE clinical studies and Bioequivalence:

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in the heart of New Jersey's pharmaceutical R&D corridor in Princeton, NJ. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and clinical data management, regulatory submissions, and scientific communications for Phase I – IV clinical studies. CRO services are provided out of our corporate headquarters office.

ABR also maintains a 72-bed, state-of-the-art Clinical Research Center in Hackensack, NJ, within 15 minutes of New York City. ABR performs a wide range of Phase I-IV studies including bioavailability, bioequivalence, first-in-man, dose escalation safety/tolerability, drug-drug interactions, fed-fasted, pharmacokinetics/pharmacodynamics, and special population studies. You may obtain more information about ABR at http://www.abr-pharma.com/.

Advanced Biomedical Research – dedicated people providing solutions through good science and innovation^SM.

Preclinical Studies:

Calvert Laboratories, Inc., located in Olyphant, PA, provides contract scientific services in the non-clinical arena to the pharmaceutical and biotechnology industries. Calvert performs preclinical pharmacology, safety pharmacology, immunology, immunotoxicology, pharmacokinetics, ADME, toxicology, in-vivo & in-vitro drug interactions, electrophysiology studies and archiving services. Calvert is providing outstanding science, operational excellence and regulatory assuredness in the design, management and implementation of nonclinical safety programs.

Visit their website for more information: http://www.calvertpreclin.com/.

World-class clinical laboratory science and unparalleled, personalized service are the uncompromised characteristics of PRL Central Laboratory Services. Our goal is to contribute exceptional value to your clinical trials, satisfy your expectations and earn your confidence.

PRL Central Laboratory Services specializes in comprehensive diagnostic testing, with focus on protocol requirements for timely results and accurate data management, in support of all phases of clinical trials.

PRL Central Laboratory Services works with you to design study specific specimen kits and requisitions, and provides detailed collection and processing instructions.

PRL Central Laboratory Services offers an extensive menu of safety and specialized, clinical testing in a wide range of therapeutic areas; 24 hours per day-7 days per week-365 days per year.

Visit the PRL Central Laboratory Services website: www.atPRLweCARE.com

Active Pharmaceutical Ingredient Development and Manufacturer for New Chemical Entities:

Plantes & Industrie, a division of Pierre Fabre in Gaillac, France, puts 30 years of R&D and production at your disposal. P&I can intervene at any step of your chemical development projects. From synthetic route research to full-scale production, they offer you the skills and expertise to carry out and/or develop processes according to cGMP standards. Whatever you need, P&I is able to respond to any sort of request from a few hundreds grams for clinical trials to several tons.

In particular, P&I has built up a specific expertise in the development and manufacturing of cytotoxic or high potency pharmaceutical ingredients, combining our activities in natural products extraction, semi-synthesis and specialized purification techniques. P&I is at the forefront of implementing several unique technologies, including supercritical fluid extractions, pharmaceutical nanopowders for enhanced bioavailability, complexation with cyclodextrins, fluorinations, bulk freeze-drying, ultrafiltration, and industrial-scale CPC and HPLC purifications.

Visit the Plantes & Industrie website: http://www.plantes-industrie.com/homepage.

Heraeus, the precious metals and technology group headquartered in Hanau, Germany, is a global, private company in the business segments of precious metals, dental health, sensors, quartz glass, and specialty lighting sources. With revenues of € 8.3 billion and more than 9,800 employees worldwide in over 100 subsidiaries and associated companies, Heraeus has stood out for more than 150 years as one of the worldwide leading companies involved in precious metals and materials technology.

This exceptional expertise has served as a basis for the synthesis of platinum based Active Pharmaceutical Ingredients within Heraeus' Pharma Business Unit: Cisplatin, Carboplatin and Oxaliplatin - products which play an elementary role in fighting cancer for more than 20 years (these products are available for purchase via Flavine North America, Inc.).

Highly active and cytotoxic anti-cancer APIs are the typical compounds produced at Heraeus - but they are not limited to these types of compounds. Also Diagnostics APIs for cancer detection and further organic hAPIs are within Heraeus' portfolio and they are open to expand capabilities based on the needs of our clients. Besides their core competency in highly potent active ingredients, Heraeus has developed advanced technology in industrial fermentation processes for potent compounds.

Heraeus hAPI activities are performed under cGMP guidelines and at FDA approved facilities.

Visit Heraeus' website: http://www.wc-heraeus.com/pharma.